Core Insights - The article highlights recent research reports on major stocks including Visa Inc., The Charles Schwab Corp., and Amphenol Corp., as well as micro-cap stocks Autoscope Technologies Corp. and United-Guardian, Inc. [2][4] Visa Inc. - Visa's shares have outperformed the Zacks Financial Transaction Services industry over the past year, with a gain of +11.1% compared to the industry's decline of -8.7% [4] - Total revenue rose 11% year-over-year in FY25, with cross-border growth at 13% [5] - The company faces rising client incentives and expenses, which may impact margin growth, with adjusted costs expected to rise nearly 11% in FY26 [6] The Charles Schwab Corp. - Charles Schwab's shares gained +21.8% over the past year, while the Zacks Financial - Investment Bank industry gained +37% [7] - The company is expected to maintain elevated expenses due to ongoing marketing investments, with a projected CAGR of 7% in expenses by 2027 [7][9] - Strategic buyouts and branch expansion efforts are anticipated to drive client assets, with total client assets expected to grow at a CAGR of 8.2% by 2027 [8][9] Amphenol Corp. - Amphenol's shares increased by +88.5% over the past year, slightly underperforming the Zacks Electronics - Connectors industry, which gained +89.8% [10] - The company benefits from a diversified business model and strong demand for high-speed and power interconnect products, with fourth-quarter 2025 earnings expected to grow between 62% and 65% year-over-year [12] - However, macroeconomic uncertainty and competition pose significant challenges [12] Autoscope Technologies Corp. - Autoscope Technologies has underperformed the Zacks Technology Services industry, with a decline of -5.5% compared to the industry's gain of +20.6% [13] - The company is focusing on AI-driven detection and multi-sensor integration, which supports future upgrades and broader use cases [13][14] - A new long-duration contract in Georgia enhances revenue visibility and diversifies its income sources [14][15] United-Guardian, Inc. - United-Guardian's shares have underperformed the Zacks Medical - Products industry, with a decline of -34.4% compared to -0.5% for the industry [16] - The company faces challenges such as declining profitability and operational strain, but it has strengths in expanding its pharmaceutical portfolio and stable medical products [17] - The upcoming launch of Natrajel is expected to provide a differentiated growth avenue [17]

Core Insights - The consumer staples sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Company Summaries - **SunOpta Inc (NASDAQ:STKL)**: Reported better-than-expected quarterly earnings with a 6.2% increase in stock price to close at $3.58. The stock has fallen approximately 35% over the past month, with an RSI value of 29.9 and a 52-week low of $3.32. The company has a momentum score of 91.92 and a value score of 93.51 [7] - **Energizer Holdings Inc (NYSE:ENR)**: Reported mixed fourth-quarter results and provided first-quarter EPS guidance below estimates. The stock rose 3.4% to close at $18.10, despite a 25% decline over the past month. The RSI value is 26, with a 52-week low of $17.13 [7] - **United-Guardian**: Experienced a decline in third-quarter earnings, with a 0.1% decrease in stock price to close at $5.68. The stock has fallen around 22% over the past month, with an RSI value of 21.4 and a 52-week low of $5.58. The company noted increased sales in pharmaceuticals and medical products but a decrease in cosmetic ingredient sales due to geopolitical issues [7]

Core Insights - The consumer staples sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Company Summaries - **SunOpta Inc (NASDAQ:STKL)**: Reported better-than-expected quarterly earnings with a 6.2% increase in stock price to $3.58. The stock has fallen approximately 35% over the past month, with an RSI value of 29.9 and a 52-week low of $3.32 [7] - **Energizer Holdings Inc (NYSE:ENR)**: Reported mixed fourth-quarter results and provided first-quarter EPS guidance below estimates. The stock rose 3.4% to close at $18.10, but has decreased around 25% in the last month, with an RSI value of 26 and a 52-week low of $17.13 [7] - **United-Guardian**: Experienced a decline in third-quarter earnings, with a 0.1% decrease in stock price to $5.68. The stock has fallen about 22% over the past month, with an RSI value of 21.4 and a 52-week low of $5.58 [7]